TY - JOUR
T1 - Noncytotoxic functions of killer cell granzymes in viral infections
AU - de Jong, Lisanne C.
AU - Crnko, Sandra
AU - Broeke, Toine ten
AU - Bovenschen, Niels
N1 - Publisher Copyright:
Copyright: © 2021 de Jong et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PY - 2021/9
Y1 - 2021/9
N2 - Cytotoxic lymphocytes produce granules armed with a set of 5 serine proteases (granzymes (Gzms)), which, together with the pore-forming protein (perforin), serve as a major defense against viral infections in humans. This granule-exocytosis pathway subsumes a well-established mechanism in which target cell death is induced upon perforin-mediated entry of Gzms and subsequent activation of various (apoptosis) pathways. In the past decade, however, a growing body of evidence demonstrated that Gzms also inhibit viral replication and potential reactivation in cell death–independent manners. For example, Gzms can induce proteolysis of viral or host cell proteins necessary for the viral entry, release, or intracellular trafficking, as well as augment pro-inflammatory antiviral cytokine response. In this review, we summarize current evidence for the noncytotoxic mechanisms and roles by which killer cells can use Gzms to combat viral infections, and we discuss the potential thereof for the development of novel therapies.
AB - Cytotoxic lymphocytes produce granules armed with a set of 5 serine proteases (granzymes (Gzms)), which, together with the pore-forming protein (perforin), serve as a major defense against viral infections in humans. This granule-exocytosis pathway subsumes a well-established mechanism in which target cell death is induced upon perforin-mediated entry of Gzms and subsequent activation of various (apoptosis) pathways. In the past decade, however, a growing body of evidence demonstrated that Gzms also inhibit viral replication and potential reactivation in cell death–independent manners. For example, Gzms can induce proteolysis of viral or host cell proteins necessary for the viral entry, release, or intracellular trafficking, as well as augment pro-inflammatory antiviral cytokine response. In this review, we summarize current evidence for the noncytotoxic mechanisms and roles by which killer cells can use Gzms to combat viral infections, and we discuss the potential thereof for the development of novel therapies.
KW - Granzymes/immunology
KW - Humans
KW - T-Lymphocytes/immunology
KW - Virus Diseases/immunology
UR - http://www.scopus.com/inward/record.url?scp=85115248292&partnerID=8YFLogxK
U2 - 10.1371/journal.ppat.1009818
DO - 10.1371/journal.ppat.1009818
M3 - Review article
C2 - 34529743
SN - 1553-7366
VL - 17
SP - 1
EP - 19
JO - PLoS Pathogens
JF - PLoS Pathogens
IS - 9
M1 - e1009818
ER -